Company Bioqual, Inc. Other OTC
Equities
BIOQ
US09065J1016
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Commercial and Other
82.6
%
| 54 | 81.6 % | 52 | 82.6 % | -4.06% |
National Institutes of Health
17.4
%
| 12 | 18.4 % | 11 | 17.4 % | -10.64% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 66 | 100.0 % | 63 | 100.0 % | -5.27% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark G. Lewis
CEO | Chief Executive Officer | 69 | 01/03/01 |
Charles C Kirk
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 09/22/09 | |
Chief Operating Officer | - | - | |
Nancy A. Madden
ADM | Chief Administrative Officer | - | 01/03/01 |
Chander P. Sarma
CTO | Chief Tech/Sci/R&D Officer | - | 01/94/01 |
Director/Board Member | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 87 | 01/15/01 | |
Mark G. Lewis
CEO | Chief Executive Officer | 69 | 01/03/01 |
Director/Board Member | - | - | |
David B. Landon
BRD | Director/Board Member | 61 | 19/17/19 |
Director/Board Member | 86 | 01/91/01 | |
Director/Board Member | 68 | 01/92/01 | |
Director/Board Member | 48 | 25/18/25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,599,408 | 894,416 ( 55.92 %) | 704,992 ( 44.08 %) | 55.92 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+44.48% | 55.07B | |
+43.79% | 40.22B | |
-0.86% | 41.79B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |